Xeltis Revenue and Competitors
Estimated Revenue & Valuation
- Xeltis's estimated annual revenue is currently $17.1M per year.
- Xeltis's estimated revenue per employee is $233,808
Employee Data
- Xeltis has 73 Employees.
- Xeltis grew their employee count by 24% last year.
Xeltis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP US Clinical Affairs | Reveal Email/Phone |
4 | VP Clinical Business Development | Reveal Email/Phone |
5 | Director R&D | Reveal Email/Phone |
6 | Director Regulatory Affairs | Reveal Email/Phone |
7 | Director Clinical Operations | Reveal Email/Phone |
8 | Director Quality | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Finance Director (ai) | Reveal Email/Phone |
Xeltis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.5M | 4 | -81% | N/A | N/A |
#2 | $1.8M | 7 | N/A | N/A | N/A |
#3 | $88.6M | 353 | 38% | N/A | N/A |
#4 | $29.4M | 78 | -19% | N/A | N/A |
#5 | $17.1M | 73 | 24% | N/A | N/A |
#6 | $1.3M | 1 | -75% | N/A | N/A |
#7 | $3M | 12 | 0% | N/A | N/A |
#8 | $4.5M | 17 | 13% | N/A | N/A |
#9 | $13.6M | 39 | -11% | N/A | N/A |
#10 | $6.5M | 15 | -29% | N/A | N/A |
What Is Xeltis?
Xeltis is a clinical-stage company developing medical devices enabling cardiovascular restoration. Xeltis medical device platform comprises the first-ever bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR): the natural restoration of the complex body part they replace upon implantation. www.xeltis.com Please note: Xeltis cannot provide any information to individual patients in relations to clinical trials, due to privacy and clinical practice regulations; please contact the relevant trial centres for any enquiries. www.xeltis.com
keywords:N/A
N/A
Total Funding
73
Number of Employees
$17.1M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xeltis News
... Scope And Outlook | Abbott Laboratories, BioVentrix Inc., Edwards Lifesciences Corp., CryoLife Inc., Xeltis AG, NeoChord Inc.
These findings from an ongoing first-in-human study of the Axess graft (Xeltis) are being presented for the first time by trial investigator...
Other Companies in Zurich
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 73 | 22% | N/A |
#2 | $17.7M | 73 | 22% | N/A |
#3 | $10.8M | 73 | 52% | N/A |
#4 | N/A | 73 | 38% | N/A |
#5 | N/A | 74 | 54% | N/A |